X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (20) 20
humans (14) 14
ophthalmology (13) 13
chemistry (10) 10
metallurgy (10) 10
animals (9) 9
male (9) 9
microbiology (9) 9
benzalkonium chloride (8) 8
benzalkonium compounds - toxicity (8) 8
conjunctiva - drug effects (7) 7
microscopy, confocal (7) 7
ocular surface (7) 7
preservatives, pharmaceutical - toxicity (7) 7
apoptosis (6) 6
beer (6) 6
biochemistry (6) 6
conjunctiva - pathology (6) 6
enzymology (6) 6
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (6) 6
mutation or genetic engineering (6) 6
spirits (6) 6
vinegar (6) 6
wine (6) 6
conjunctiva - metabolism (5) 5
epithelium, corneal - drug effects (5) 5
epithelium, corneal - pathology (5) 5
immunology (5) 5
in-vitro (5) 5
rabbits (5) 5
adult (4) 4
biochemistry & molecular biology (4) 4
cell survival - drug effects (4) 4
cornea - drug effects (4) 4
cornea - pathology (4) 4
drugs (4) 4
expression (4) 4
female (4) 4
flow cytometry (4) 4
heterocyclic compounds (4) 4
human necessities (4) 4
hygiene (4) 4
inflammation (4) 4
medical or veterinary science (4) 4
medicine & public health (4) 4
organic chemistry (4) 4
preparations for medical, dental, or toilet purposes (4) 4
preservatives (4) 4
rats (4) 4
rats, inbred lew (4) 4
sense organs (4) 4
specific therapeutic activity of chemical compounds ormedicinal preparations (4) 4
specific use of cosmetics or similar toiletpreparations (4) 4
vivo confocal microscopy (4) 4
analysis (3) 3
antihypertensive agents - toxicity (3) 3
apoptosis - drug effects (3) 3
cell survival (3) 3
cells, cultured (3) 3
cloprostenol - analogs & derivatives (3) 3
conjunctiva - cytology (3) 3
cornea (3) 3
cosmetic products (3) 3
disease models, animal (3) 3
disease transmission (3) 3
dose-response relationship, drug (3) 3
epithelial cells - drug effects (3) 3
epithelial cells - metabolism (3) 3
eye diseases (3) 3
glaucoma patients (3) 3
hiv (3) 3
hiv infections - drug therapy (3) 3
hiv infections - prevention & control (3) 3
immunohistochemistry (3) 3
infectious disease transmission, vertical - prevention & control (3) 3
infectious diseases (3) 3
intercellular adhesion molecule-1 - metabolism (3) 3
ophthalmic solutions - toxicity (3) 3
pregnancy (3) 3
pregnancy complications, infectious - drug therapy (3) 3
reverse transcriptase polymerase chain reaction (3) 3
risk factors (3) 3
toxicology (3) 3
travoprost (3) 3
administration, topical (2) 2
amides (2) 2
anatomy (2) 2
anatomy & morphology (2) 2
anatomy & physiology (2) 2
anti-hiv agents - therapeutic use (2) 2
antihypertensive agents - pharmacology (2) 2
antiquités gréco-romaines (2) 2
antiretroviral drugs (2) 2
antiretroviral therapy (2) 2
barrier function (2) 2
benzalkonium compounds - adverse effects (2) 2
bimatoprost (2) 2
cell count (2) 2
cell line (2) 2
cell proliferation (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Trinity College (John W Graham) - Reference (2) 2
Pontifical Inst. Mediaeval Studies - Rare Book (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Robarts - Reference (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 03/2011, Volume 95, Issue 6, p. 869
Purpose: Using an established three-dimensional (3D) toxicological model based on reconstituted human corneal epithelium (HCE), this study investigated the... 
Journal Article
Advances in Therapy, ISSN 0741-238X, 4/2011, Volume 28, Issue 4, pp. 311 - 325
The aim of this study was to use a validated acute rabbit model to test the toxicity of a novel formulation of fixed-combination travoprost 0.004%/timolol 0.5%... 
ocular surface toxicity | timolol | Rheumatology | Oncology | Internal Medicine | travoprost | benzalkonium chloride | Xalacom | Duotrav | latanoprost | polyquad | Medicine & Public Health | in vivo | Cardiology | Pharmacology/Toxicology | Endocrinology | In vivo | Ocular surface toxicity | Polyquad | Benzalkonium chloride | Timolol | Latanoprost | Travoprost | MEDICINE, RESEARCH & EXPERIMENTAL | POLYQUATERNIUM-1 | MEDICATIONS | TOXICITY | PREVALENCE | CONJUNCTIVAL | IN-VIVO | PHARMACOLOGY & PHARMACY | GLAUCOMA | IMPRESSION CYTOLOGY | PROSTAGLANDIN ANALOGS | Polymers - administration & dosage | Antihypertensive Agents - administration & dosage | Timolol - administration & dosage | Male | Epithelium, Corneal - pathology | Ocular Hypertension - drug therapy | Conjunctiva - pathology | Prostaglandins F, Synthetic - administration & dosage | Epithelium, Corneal - drug effects | Ophthalmic Solutions | Anti-Bacterial Agents - adverse effects | Polymers - adverse effects | Disease Models, Animal | Timolol - adverse effects | Cell Survival - drug effects | Rabbits | Cloprostenol - adverse effects | Preservatives, Pharmaceutical - adverse effects | Cloprostenol - administration & dosage | Ocular Hypertension - pathology | Benzalkonium Compounds - adverse effects | Benzalkonium Compounds - administration & dosage | Treatment Outcome | Prostaglandins F, Synthetic - adverse effects | Antihypertensive Agents - adverse effects | Cloprostenol - analogs & derivatives | Animals | Conjunctiva - drug effects | Preservatives, Pharmaceutical - administration & dosage | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Immunohistochemistry | Surface active agents | Analysis | Ophthalmic drugs | Health technology assessment
Journal Article
by Sibiude, Jeanne and Le Chenadec, Jérôme and Bonnet, Damien and Tubiana, Roland and Faye, Albert and Dollfus, Catherine and Mandelbrot, Laurent and Delmas, Sandrine and Lelong, Nathalie and Khoshnood, Babak and Warszawski, Josiane and Blanche, Stéphane and Crenn-Hebert, Catherine and Floch-Tudal, Corinne and Mazy, Fabienne and Joras, Marine and Meier, Françoise and Mortier, Emmanuel and Briquet, Catherine and Duro, Dominique and Ichou, Houria and Marty, Laurence and Ceccaldi, Pierre-François and Banige, Maïa and Uludag, Agnès Villemant and Zarouk, Virginie and Lefort, Agnès and Ben Salah, Mariam and Hittinger, Gilles and Chamouilli, Jean-Marc and Burle, Christian and Lafeuillade, Alain and Philip, Gisèle and Medus, Marie and Bachelard, Germaine and Malet, Martine and Dendale-Nguyen, Joëlle and Guimard, Thomas and Guimard, Karine and Brossier, Jean-Pierre and Perré, Philippe and Esnault, Jean-Luc and Stragier, Olivier Bollengier and Leautez-Nainville, Sophie and Suaud, Isabelle and Martha, Sandrine-Anne and Martha, Benoît and Maurel, Elise and Françoise, Michel and Barat, Muriel and Murger, Patricia and Rouha, Mahfoud and Lumbroso, Philippe and Checoury, Alain and Perfezou, Pascale and Blondin, Gilles and Duthé, Jean-Charles and Ansart, Séverine and Martin, Luc De Saint and Le Moine, Philippe and Daniel, Corinne and Calvez, Christian and Boutaric, Emmanuelle and Rohan, Jennifer and Arvieux, Cédric and Bauville, Estelle and Dupre, Christelle and Lotton, Pascal and Ouamara-Digue, Enora and Poinsignon, Yves and Grelier, Anne and Mousset, Gaetane and Cudeville, Corinne and Mouton-Rioux, Virginie and Niault, Mathilde and Belzic, Isabelle and Moreau, Philippe and Le Coz, Marie-Françoise and Vaillant, Odile Luycx and De Morel, Philippe and Vitrat, Virginie and Tardif, Didier and Gaillat, Jacques and Vanderbergh, Anne and Braig, Suzanne and Clavere, Gaelle and Dehlinger-Paul, Marion and Mohamed, Khaled and Echard, Marie and Camus, Michel and Heller-Roussin, Brigitte and Winter, Cécile and Benveniste, Elyane and Firtion, Ghislaine and Pannier, Emmanuelle and Costa, Myriam and Launay, Odile and Ceron, Dominique Salmon and Belkacem, Touraia and Matheron, Sophie and ... and French Natl Agcy Res AIDS Viral He and French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial
Clinical Infectious Diseases, ISSN 1058-4838, 07/2015, Volume 61, Issue 2, pp. 270 - 280
Background. Antiretroviral (ARV) regimens during pregnancy are highly effective in preventing mother-to-child transmission of human immunodeficiency virus... 
PMTCT | zidovudine | heart function | randomized trial | congenital heart defects | INFECTIOUS DISEASES | INFECTED WOMEN | MOTHER | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | BIRTH-DEFECTS | PREVALENCE | IMMUNOLOGY | CD-1 MICE | PREGNANCY | TRANSMISSION | HIV | CHILDREN BORN | HIV Infections - prevention & control | Heart Septal Defects, Ventricular - epidemiology | Lamivudine - administration & dosage | Pregnancy Complications, Infectious - virology | Follow-Up Studies | Heart Defects, Congenital - etiology | Humans | Infant | Male | Pregnancy Trimester, First | Zidovudine - administration & dosage | Lamivudine - adverse effects | Young Adult | Uterus | Heart Septal Defects, Ventricular - etiology | Heart Septal Defects, Ventricular - diagnosis | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | France | Echocardiography | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | Pregnancy | Pregnancy Complications, Infectious - drug therapy | Sex Factors | Heart Defects, Congenital - epidemiology | HIV Infections - drug therapy | Heart Defects, Congenital - diagnosis | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Drug Combinations | Prevention | Usage | Maternal health services | Disease transmission | Clinical trials | Dosage and administration | Management | Drug therapy | HIV infection | Zidovudine | Risk factors | Heart | Confidence intervals | Antiretroviral drugs | Congenital diseases | Prenatal development | Index Medicus
Journal Article
Journal Article